VEGFA and acute kidney injury: Ang-1 mimetics, such as Vasculotide and Hepta-ANG1, have demonstrated superior protective effects and safety profiles compared to VEGF-based therapies in various animal models of AKI by restoring vascular homeostasis (Kumpers et al., 2011).